Alison Backen

3.2k total citations · 1 hit paper
41 papers, 2.4k citations indexed

About

Alison Backen is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Alison Backen has authored 41 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 9 papers in Surgery and 9 papers in Molecular Biology. Recurrent topics in Alison Backen's work include Pancreatic and Hepatic Oncology Research (10 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (7 papers) and Neuroendocrine Tumor Research Advances (6 papers). Alison Backen is often cited by papers focused on Pancreatic and Hepatic Oncology Research (10 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (7 papers) and Neuroendocrine Tumor Research Advances (6 papers). Alison Backen collaborates with scholars based in United Kingdom, United States and Sweden. Alison Backen's co-authors include Caroline Dive, Matthew Krebs, Fiona Blackhall, Tim Ward, Lynsey Priest, Lee Lancashire, Robert Szczepaniak‐Sloane, Alastair Greystoke, Karen Morris and Cong Zhou and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Alison Backen

41 papers receiving 2.4k citations

Hit Papers

Clinical Significance and Molecular Characteristics of Ci... 2012 2026 2016 2021 2012 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Clinical Significance and Molecular Characteristics of Circulating Tumor Cells and Circulating Tumor Microemboli in Patients With Small-Cell Lung Cancer
    2012 675 citations Matthew Krebs, Lee Lancashire et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alison Backen United Kingdom 22 1.5k 867 713 573 328 41 2.4k
E. Ramsay Camp United States 28 1.6k 1.0× 771 0.9× 1.2k 1.7× 563 1.0× 415 1.3× 65 2.8k
Gilbert Spizzo Austria 29 1.7k 1.1× 723 0.8× 2.1k 2.9× 488 0.9× 356 1.1× 70 3.8k
Huaxiang Xu China 23 1.0k 0.6× 477 0.6× 735 1.0× 281 0.5× 173 0.5× 54 2.1k
Suxia Luo China 25 2.0k 1.3× 745 0.9× 1.3k 1.8× 793 1.4× 296 0.9× 108 3.5k
Su Yin Lim Australia 28 1.6k 1.1× 474 0.5× 1.3k 1.8× 415 0.7× 160 0.5× 50 3.1k
Fabiana Tatangelo Italy 37 1.7k 1.1× 464 0.5× 653 0.9× 534 0.9× 653 2.0× 129 3.2k
Mengke Niu China 19 1.8k 1.2× 421 0.5× 1.0k 1.4× 494 0.9× 169 0.5× 34 3.3k
Oronzo Brunetti Italy 35 1.5k 1.0× 783 0.9× 1.1k 1.5× 525 0.9× 440 1.3× 126 3.1k
Ryusei Matsuyama Japan 37 1.8k 1.2× 869 1.0× 1.1k 1.5× 1.2k 2.0× 814 2.5× 168 3.8k
Sapna P. Patel United States 29 1.8k 1.1× 315 0.4× 1.5k 2.1× 473 0.8× 159 0.5× 210 3.6k

Countries citing papers authored by Alison Backen

Since Specialization
Citations

This map shows the geographic impact of Alison Backen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison Backen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison Backen more than expected).

Fields of papers citing papers by Alison Backen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alison Backen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison Backen. The network helps show where Alison Backen may publish in the future.

Co-authorship network of co-authors of Alison Backen

This figure shows the co-authorship network connecting the top 25 collaborators of Alison Backen. A scholar is included among the top collaborators of Alison Backen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alison Backen. Alison Backen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
4.
Papaxoinis, George, et al.. (2020). Financial burden and financial toxicity in patients with colorectal, gastro-oesophageal, and pancreatobiliary cancers: A UK study. Journal of Cancer Policy. 25. 100236–100236. 4 indexed citations
5.
Backen, Alison, Ángela Lamarca, Richard Hubner, Mairéad G. McNamara, & Juan W. Valle. (2020). HPB cancers in older patients | inclusion of older/senior patients in clinical trials. European Journal of Surgical Oncology. 47(3). 597–602. 4 indexed citations
6.
Papaxoinis, George, et al.. (2019). Capecitabine and Temozolomide in Patients with Advanced Pulmonary Carcinoid Tumours. Neuroendocrinology. 110(5). 413–421. 27 indexed citations
7.
Jayson, Gordon C., Prakash Manoharan, James P.B. O’Connor, et al.. (2019). Novel phase I trial design to evaluate the addition of cediranib or selumetinib to preoperative chemoradiotherapy for locally advanced rectal cancer: the DREAMtherapy trial. European Journal of Cancer. 117. 48–59. 4 indexed citations
8.
Barriuso, Jorge, Ángela Lamarca, Jamie Weaver, et al.. (2019). Early recognition of anorexia through patient-generated assessment predicts survival in patients with oesophagogastric cancer. PLoS ONE. 14(11). e0224540–e0224540. 17 indexed citations
9.
Lamarca, Ángela, Salvatore Galdy, Jorge Barriuso, et al.. (2018). The HER3 pathway as a potential target for inhibition in patients with biliary tract cancers. PLoS ONE. 13(10). e0206007–e0206007. 17 indexed citations
10.
Backen, Alison, Andre Lopes, Harpreet Wasan, et al.. (2018). Circulating biomarkers during treatment in patients with advanced biliary tract cancer receiving cediranib in the UK ABC-03 trial. British Journal of Cancer. 119(1). 27–35. 22 indexed citations
11.
Lamarca, Ángela, Emma Elliott, Jorge Barriuso, et al.. (2016). Chemotherapy for advanced non-pancreatic well-differentiated neuroendocrine tumours of the gastrointestinal tract, a systematic review and meta-analysis: A lost cause?. Cancer Treatment Reviews. 44. 26–41. 40 indexed citations
12.
Valle, Juan W., Harpreet Wasan, Andre Lopes, et al.. (2015). Cediranib or placebo in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer (ABC-03): a randomised phase 2 trial. The Lancet Oncology. 16(8). 967–978. 197 indexed citations
13.
Backen, Alison, Andrew G. Renehan, Andrew R. Clamp, et al.. (2014). The Combination of Circulating Ang1 and Tie2 Levels Predicts Progression-Free Survival Advantage in Bevacizumab-Treated Patients with Ovarian Cancer. Clinical Cancer Research. 20(17). 4549–4558. 52 indexed citations
14.
Krebs, Matthew, Jianmei Hou, Robert Szczepaniak‐Sloane, et al.. (2011). Analysis of Circulating Tumor Cells in Patients with Non-small Cell Lung Cancer Using Epithelial Marker-Dependent and -Independent Approaches. Journal of Thoracic Oncology. 7(2). 306–315. 371 indexed citations
15.
Khoja, Leila, Alison Backen, Lia P. Menasce, et al.. (2011). A pilot study to explore circulating tumour cells in pancreatic cancer as a novel biomarker. British Journal of Cancer. 106(3). 508–516. 208 indexed citations
16.
O’Connor, James P.B., Alan Jackson, Geoff J.M. Parker, et al.. (2010). Identification of early predictive imaging biomarkers and their relationship to serological angiogenic markers in patients with ovarian cancer with residual disease following cytotoxic therapy. Annals of Oncology. 21(10). 1982–1989. 25 indexed citations
17.
Backen, Alison, Jeffrey L. Cummings, Claire L. Mitchell, et al.. (2009). ‘Fit-for-purpose’ validation of SearchLight multiplex ELISAs of angiogenesis for clinical trial use. Journal of Immunological Methods. 342(1-2). 106–114. 29 indexed citations
18.
Backen, Alison, et al.. (2007). Heparan sulphate synthetic and editing enzymes in ovarian cancer. British Journal of Cancer. 96(10). 1544–1548. 54 indexed citations
19.
Whitworth, Melissa, Alison Backen, Andrew R. Clamp, et al.. (2005). Regulation of Fibroblast Growth Factor-2 Activity by Human Ovarian Cancer Tumor Endothelium. Clinical Cancer Research. 11(12). 4282–4288. 25 indexed citations
20.
Backen, Alison, et al.. (2000). Evaluation of theCaMAL2 promoter for regulated expression of genes inCandida albicans. Yeast. 16(12). 1121–1129. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by E. Ramsay Camp Breakdown of academic impact, for papers by Gilbert Spizzo Breakdown of academic impact, for papers by Huaxiang Xu Breakdown of academic impact, for papers by Suxia Luo Breakdown of academic impact, for papers by Su Yin Lim Breakdown of academic impact, for papers by Fabiana Tatangelo Breakdown of academic impact, for papers by Mengke Niu Breakdown of academic impact, for papers by Oronzo Brunetti Breakdown of academic impact, for papers by Ryusei Matsuyama Breakdown of academic impact, for papers by Sapna P. Patel
Rankless by CCL
2026